Dr. Robert Harrington is Arthur L. Bloomfield Professor of Medicine and Chairman of the Department of Medicine at Stanford University. He received his undergraduate degree in English from the College of the Holy Cross Worcester, Mass. He attended Dartmouth Medical School and received his medical degree from Tuft University School of Medicine in 1986. He was an intern, resident, and the chief medical resident in internal medicine at the University of Massachusetts Medical Center. He was a fellow in cardiology at Duke University Medical Center, where he received training in interventional cardiology and research training in the Duke Databank for Cardiovascular Diseases. Dr. Harrington was previously the director of the Duke Clinical Research Institute (DCRI). His research interests include evaluating antithrombotic therapies to treat acute ischemic heart disease and to minimize the acute complications of percutaneous coronary procedures, studying the mechanism of disease of the acute coronary syndromes, understanding the issue of risk stratification in the care of patients with acute ischemic coronary syndromes, trying to better understand and improve upon the methodology of clinical trials. He is the recipient of an NIH Roadmap contract to investigate “best practices” among clinical trial networks.
He has authored more than 400 peer-reviewed manuscripts, reviews, book chapters, and editorials. He is an associate editor of the American Heart Journal and an editorial board member for the JACC. He is a senior editor of the 13th edition of Hurst’s The Heart. He is a Fellow of the ACC, the AHA, the ESC, the Society of Cardiovascular Angiography and Intervention, and the American College of Chest Physicians. He recently served as a member and the chair of the Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee.